Microbot Medical MBOT Deferred Tax Liabilities Operating Leases Rightof Use Assets
Deferred Tax Liabilities Operating Leases Rightof Use Assets at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept MBOT:DeferredTaxLiabilitiesOperatingLeasesRightofUseAssets.
The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's deferred tax liabilities operating leases rightof use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's deferred tax liabilities operating leases rightof use assets?
- Microbot Medical (MBOT) reported deferred tax liabilities operating leases rightof use assets of $191K in Q4 2025.
- How has Microbot Medical's deferred tax liabilities operating leases rightof use assets changed year-over-year?
- Microbot Medical's deferred tax liabilities operating leases rightof use assets increased by 536.7% year-over-year, from $30K to $191K.
- What is the long-term trend for Microbot Medical's deferred tax liabilities operating leases rightof use assets?
- Over 4 years (2021 to 2025), Microbot Medical's deferred tax liabilities operating leases rightof use assets has grown at a 6.6% compound annual growth rate (CAGR), from $148K to $191K.
- What does deferred tax liabilities operating leases rightof use assets mean?
- This metric represents the deferred tax liabilities arising from the difference between the book value of right-of-use assets and their tax base. It reflects the future tax consequences of capitalizing operating leases under current accounting standards. Tracking this liability is important for understanding the net tax impact of the company's lease portfolio on its long-term financial position.